Accrued liabilities as of June 30, 2024 and December 31, 2023, are as follows (in thousands):
June 30,
December 31,
2024
2023
Accrued licensing, milestone and royalty payments
$
4,522
3,452
Accrued clinical costs
551
597
Accrued compensation and board fees
3,184
3,858
Accrued manufacturing costs
2,078
2,531
Accrued sales reserves
1,681
2,309
Other
772
419
Total
12,788
13,166
No definition available.
Tabular disclosure of the components of accrued liabilities.